AngioDynamics: Growth Remains Under The Radar
Source: SeekingAlpha
2025-12-29 18:47:22 ET
Slow progress is still progress, and although AngioDynamics ( ANGO ) arguably still does not get its due in the market, the company continues to execute at an improved level. Solid growth in the faster-growing Medical Tech segment remains the key driver, as the company has credible growth leverage in peripheral atherectomy, embolectomy, and less-invasive cancer treatment, but better margins would certainly help the story....
Read the full article on Seeking Alpha
For further details see:
AngioDynamics: Growth Remains Under The Radar
AngioDynamics Inc.
NASDAQ: ANGO
ANGO Trading
0.85% G/L:
$10.665 Last:
110,206 Volume:
$10.62 Open:
ANGO Latest News
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
February 23, 2026 04:30:00 pm
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
February 19, 2026 08:30:00 am
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform
February 05, 2026 08:00:00 am
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care
ANGO Stock Data
$455,039,941
38,744,343
2.99%
58
N/A
Medical Equipment & Supplies
Healthcare
US
Latham
